http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2372910-C1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_213d4d617889b8c30a9e4a073d237b81 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-245 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-43 |
filingDate | 2008-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2009-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1deef2ae3f3a5af569803e782289e9d6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a0dc820370ba52922ee6de73067b7c5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d75db6d0668d651aa39cda0c6d334ef1 |
publicationDate | 2009-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2372910-C1 |
titleOfInvention | Method for microcyst prevention in patients with cystic tuberculosis |
abstract | FIELD: medicine. n SUBSTANCE: invention concerns medicine, particularly phthisiourology and covers prevention of development of microcystitis in patients suffering from cystic tuberculosis. It is ensured by introduction of isoniasid by indirect lymphotropic technique through forming a local lymphostasis. Rifampicin is introduced in microclyster as a component of the medicinal cocktail containing Novocaine 0.5% 50 ml + Rifampicin 0.6 g + dimexid 5 ml. In addition, spasmex is prescribed in a dose 15 mg twice a day within 3 months. n EFFECT: providing good tolerance, the method enables stable relief of dysuria, increase of bladder capacity and effective prevention of apparent microcyst. n 2 dwg, 2 tbl, 1 ex |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2702607-C1 |
priorityDate | 2008-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 41.